CODY REESE: Open Payments
NPI 1235521279 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$483 in 14 payments from 8 companies in 2025. Trend: 2023 $843 · 2024 $845 · 2025 $483
Food & beverage: $483
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $276 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Edwards Lifesciences Corporation | 1 | $32 |
| PFIZER INC. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $20 |
| Medtronic, Inc. | 1 | $14 |
Products named: WATCHMAN FLX, FARXIGA, SAPIEN 3 Ultra RESILIA, LEQVIO, ENTRESTO, ELIQUIS, Repatha, AMPLATZER TALISMAN.
Industry payments across ID — which companies pay providers there.
